Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-24

Clinical Trial Update: Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating extended-release ropinirole (Ropinirole CR-RLS) for restless legs syndrome has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole CR-RLS (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2009-07-24